| Page 90 | Kisaco Research
  • Concrete guidance on accessing non-dilutive and dilutive funding - what’s available, what’s working, and how to get it.
  • Strategies for founders and funders to navigate uncertainty and build investable, scalable ventures in women's health.
  • How women, as both innovators and investors, are transforming the funding ecosystem - and how to leverage that shift now.
Digital Health
Innovation and Investment

Author:

Lisa Marceau

CEO
Joyuus
... read more

Lisa Marceau

CEO
Joyuus
  • Sharing new clinical outcomes and how clinical trials are evolving.
  • Exploring the link between menopause, estrogen, and cognitive decline.
  • How biomarkers, digital tools, and lifestyle interventions can improve outcomes.
Brain Health
  • Sharing the role of technology and partnerships in the design & recruitment of studies.
  • Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
  • Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
Reproductive Health
Drug Development
Med Device
  • Demystifying product-market fit in the context of digital health, where clinical need, usability, and reimbursement must align.
  • Identifying key indicators—user adoption, engagement, and outcomes—that show readiness to scale.
  • Strategies for translating validated need into scalable, sustainable digital health solutions.
Innovation and Investment
  • Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition.
  • Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health.
  • Sharing advancements to educate clinical trial patients about menopause.
Menopause and Longevity
Drug Development
 

Johan van Hylckama

CSO
Freya Biosciences

Johan van Hylckama

CSO
Freya Biosciences

Johan van Hylckama

CSO
Freya Biosciences
  • How can pre-trial screening effectively predict side effects and symptoms associated with reproductive therapeutics.
  • What are the appropriate safety profiles to apply for endometriosis, PCOS, and fibroids.
Reproductive Health
Med Device

  • Exploring the current landscape of screening services in women’s cancers and market opportunities to address unmet need.

  • Sharing how AI, technology, and genetic testing can address gaps in access.

  • How providers and patients can be equipped with tools for early detection and cancer prevention.

Oncology
Digital Health

Author:

Andrea Olariu

CEO
Medicines360
... read more

Andrea Olariu

CEO
Medicines360
  • How the demand for menopause-focused functional foods, probiotics, and supplements is shaping new business opportunities.
  • Sharing insights into how nutrition and food as medicine links bone, heart, and brain health in menopause and the opportunity to address these health outcomes through wellness.
  • Expanding access to menopause nutrition solutions through pharmacies, e-commerce, consumer wellness, and employer plans.
Menopause and Longevity
Nutrition and Food as Medicine

Author:

Jacqueline Oliveira-Cella

Founder
wellBe Consulting
... read more

Jacqueline Oliveira-Cella

Founder
wellBe Consulting

Author:

Laura Katz

CEO
Helaina
... read more

Laura Katz

CEO
Helaina

Author:

Margarita Ochoa-Maya

Reproductive Endocrinologist & Senior Medical Director
Amgen
... read more

Margarita Ochoa-Maya

Reproductive Endocrinologist & Senior Medical Director
Amgen